Jehovah's Witnesses Ease Ban on Some Blood-Derived Products
The religious group now permits certain blood-derived medical products while maintaining its prohibition on whole-blood transfusions.
In a partial reversal of longstanding doctrine, Jehovah's Witnesses have relaxed their prohibition on donated blood in medical treatment. According to STAT, the religious organization now permits the use of blood-derived products. The change stops short of allowing traditional whole-blood transfusions, which remain banned.
Clinicians caring for Jehovah's Witnesses patients may need to distinguish between acceptable blood-derived therapies and whole-blood transfusions under the revised policy. The nuanced stance reflects an attempt to accommodate modern medical options while preserving the group's core prohibition.
More in Medicine & Biotech
Ebola Vaccine Trial Launches in DR Congo Outbreak Zone
Health workers in DR Congo have begun testing whether a vaccine designed for a different Ebola strain can protect against the current outbreak.
Beacon Gene Therapy for Rare Vision Loss Succeeds in Pivotal Trial
A pivotal trial of Beacon Therapeutics' gene therapy for X-linked retinitis pigmentosa improved visual acuity, clearing the path toward an FDA submission.
Alkermes orexin agonist shows early promise for ADHD
Early-stage data suggest Alkermes' orexin agonist could expand the drug class beyond sleep disorders into ADHD.
Telix to Buy ITM for $1.65B, Challenging Novartis in Radiopharma
The acquisition gives Telix a late-stage pipeline and supply network that could compete with Novartis' Lutathera.